BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3928388)

  • 1. Distribution of sodium valproate in normal whole blood and in blood from patients with renal or hepatic disease.
    Shirkey RJ; Jellett LB; Kappatos DC; Maling TJ; Macdonald A
    Eur J Clin Pharmacol; 1985; 28(4):447-52. PubMed ID: 3928388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of drugs over whole blood: I. The transport function of whole blood for valproate.
    Driessen O; Treuren L; Meijer JW
    Ther Drug Monit; 1989; 11(4):384-9. PubMed ID: 2500756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein binding of carbamazepine.
    Hooper WD; Dubetz DK; Bochner F; Cotter LM; Smith GA; Eadie MJ; Tyrer JH
    Clin Pharmacol Ther; 1975 Apr; 17(4):433-40. PubMed ID: 1122684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of quinidine in human blood.
    Hughes IE; Ilett KF; Jellett LB
    Br J Clin Pharmacol; 1975 Dec; 2(6):521-5. PubMed ID: 1234016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between phenytoin and valproic acid: plasma protein binding and metabolic effects.
    Perucca E; Hebdige S; Frigo GM; Gatti G; Lecchini S; Crema A
    Clin Pharmacol Ther; 1980 Dec; 28(6):779-89. PubMed ID: 6777108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid and diazepam interaction in vivo.
    Dhillon S; Richens A
    Br J Clin Pharmacol; 1982 Apr; 13(4):553-60. PubMed ID: 6802161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate plasma protein binding in the uremic condition.
    Brewster D; Muir NC
    Clin Pharmacol Ther; 1980 Jan; 27(1):76-82. PubMed ID: 6985855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The uptake of fentanyl by erythrocytes.
    Bower S
    J Pharm Pharmacol; 1982 Mar; 34(3):181-5. PubMed ID: 6121896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo plasma protein binding interaction between valproic acid and naproxen.
    Grimaldi R; Lecchini S; Crema F; Perucca E
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):359-63. PubMed ID: 6442704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.
    Semmes RL; Shen DD
    Epilepsia; 1991; 32(2):232-41. PubMed ID: 2004628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma protein binding interaction between valproic and salicylic acids in rhesus monkeys.
    Viswanathan CT; Levy RH
    J Pharm Sci; 1981 Nov; 70(11):1279-81. PubMed ID: 6795339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma protein binding kinetics of valproic acid over a broad dosage range: therapeutic implications.
    Gómez Bellver MJ; García Sánchez MJ; Alonso González AC; Santos Buelga D; Domínguez-Gil A
    J Clin Pharm Ther; 1993 Jun; 18(3):191-7. PubMed ID: 8345004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of valproate on free plasma phenytoin concentrations.
    Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
    Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocytes and the transport of drugs and endogenous compounds.
    Highley MS; De Bruijn EA
    Pharm Res; 1996 Feb; 13(2):186-95. PubMed ID: 8932435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of free level monitoring of antiepileptic drugs.
    Levy RH; Schmidt D
    Epilepsia; 1985; 26(3):199-205. PubMed ID: 3924585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-dose variation in plasma protein binding of sodium valproate in epileptic patients.
    Marty JJ; Kilpatrick CJ; Moulds RF
    Br J Clin Pharmacol; 1982 Sep; 14(3):399-404. PubMed ID: 6812608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients.
    Monks A; Richens A
    Clin Pharmacol Ther; 1980 Jan; 27(1):89-95. PubMed ID: 6985856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse.
    Löscher W
    J Pharmacol Exp Ther; 1978 Feb; 204(2):255-61. PubMed ID: 340640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of free fatty acids on valproic acid plasma protein binding during fasting in normal humans.
    Bowdle TA; Patel IH; Levy RH; Wilensky AJ
    Eur J Clin Pharmacol; 1982 Oct; 23(4):343-7. PubMed ID: 6816619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.